Triple
T10609989
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Dravet syndrome |
E275979
|
entity |
| Predicate | hasContraindicatedDrug |
P23156
|
FINISHED |
| Object |
vigabatrin
Vigabatrin is an antiepileptic medication that irreversibly inhibits GABA transaminase to increase brain GABA levels, used mainly for refractory seizures such as infantile spasms but associated with risks like permanent visual field loss.
|
E874312
|
NE FINISHED |
Provenance (5 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69d6aaf948d88190806cc3a8c47a3fb2 |
elicitation | completed |
| NER | batch_69d6f31b72d081908ec8029cd9f6d814 |
ner | completed |
| NED1 | batch_69d95ebe539881908aeff1cd65cf925f |
ned_source_triple | completed |
| NED2 | batch_69d961047a78819088094e02c0b99f60 |
ned_description | completed |
| NEDg | batch_69d95f81955c8190b629d57a034a4b76 |
nedg | completed |
Created at: April 8, 2026, 7:32 p.m.